Biohaven price target lowered to $66 from $68 at RBC Capital
The Fly

Biohaven price target lowered to $66 from $68 at RBC Capital

RBC Capital lowered the firm’s price target on Biohaven (BHVN) to $66 from $68 and keeps an Outperform rating on the shares. The firm’s price target reduction reflects the company’s higher than expected Q3 operating expense and the recent equity raise, though Biohaven also remains on track for key value inflecting readouts by the end of the year, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App